Literature DB >> 35350420

Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products.

Manabu Mizutani1,2, Kentaro Nakajima1, Masahiro Kino-Oka1.   

Abstract

Recent developments for the manufacturing of cell-based products have focused on the advancement of products to clinical trials or commercialization, with awareness of the importance of cost-based effectiveness in cell manufacturing. The mechanization of cell-processing operations is advantageous for the reproducibility and stability of product quality and is thought to reduce the cost-of-goods through the life cycle of the product in a scale-up system; however, few cases of the implementation exist. This study developed an estimation method for the resource expenditure of cell-processing operations in the manufacturing of cell-based products. To estimate resource expenditures, we evaluated the manufacturing processes by operations involving entering into the surrounding area of cell processing zone, materials loading, cell-processing operation, cleaning, and leaving from the surrounding area. The cell-processing operation is applicable to manual or robotic cell manufacturing system in a biosafety cabinet or an isolator system. In cases of low annual batch numbers of manufacturing (batch number <33), the resource expenditure of cell-processing operations in a robotic operation system installed in the isolator system is estimated to be higher compared with a manual operation system in the isolator system due to additional initial costs for design and fabrication of the robotic operation system containing robot arms. With increasing numbers of annual batches, the resource expenditure decreases for robotic operating system, leading to an advantageous juncture where the resource expenditure of a robotic operation system is equivalent to that of a manually operated system, whereby the labor cost for cell-processing operations rises. In addition, the expertise of operations required for cell manufacturing is suggested to foster potential risks associated with the operation skills or turnover of operators, and the cost of education and training increases due to the necessity of persistent human resource development. Collectively, revealing the approach for installation of robotic operation system in cell manufacturing.
© 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

Entities:  

Keywords:  Cell manufacturability; Cell-processing operation; Cost-of-goods; Education and training; Mechanization; Resource expenditure

Year:  2022        PMID: 35350420      PMCID: PMC8920920          DOI: 10.1016/j.reth.2022.02.004

Source DB:  PubMed          Journal:  Regen Ther        ISSN: 2352-3204            Impact factor:   3.419


expenditure for manual operation system of a product [JPY·(product)−1] expenditure for robotic operation system of a product [JPY·(product)−1] actual hourly rate of operator A [JPY·h−1] actual hourly rate of operator B [JPY·h−1] annual number of batches required for production [batch·(year)−1] number of batches performable by operator B [batch·(operator)−1] number of operator B required during the life cycle of production [operator] necessary number of the robotic operation system [unit] maximum number of batches per a robotic operation system [batch·(unit)−1] time required for each process [h] education and training time for cell-processing operation skills [h·(operator)−1]

Introduction

Regenerative medicine, or therapy using cell-based products, has begun to cure many patients through growing commercialization of products made from autologous or allogeneic cells or tissue [[1], [2], [3]]. Recent advances in the research and development of pluripotent stem cell-based products using human embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC) have resulted in the commencement of clinical trials [[4], [5], [6]]. Using pluripotent stem cells, it is theoretically feasible to produce all differentiated therapeutic cell sources that are difficult to obtain from patients or volunteer healthy donors, thus representing an essential technique for expanding therapeutic applications. When manufacturing cell-based products for therapeutic, it is necessary to design of cell manufacturability [7]. The fundamental feature for the manufacturability is in terms of maintenance of aseptic environment, assurance of processing independence, containment against contaminants and robust management, whereas the concept of cell manufacturability requires that the attainment of the desired capability of a cell manufacturing process by bridging the gap between its biological and engineering aspects. The quality of cell-based products as the output of the process is sensitive to fluctuations derived from several factors, for example, environmental noise, fluctuations in the process operation or intrinsic biological disorders. Notably, the quality of cell-based products is sensitive to fluctuations derived from the factors of operation in manufacturing processes. These intrinsic disorders lead to a compounded impact on the stability of the process. So manufacturers must have proper operational parameters in the manufacturing process and ensure maintained to deliver the required level of stability. And these design for manufacturability mean not only to assist the design of cell manufacturing processes but also to deliver cost saving through process simplification based upon the governing principles of cell behavior. As the raw materials for cell-based products shift from somatic cells or tissue to pluripotent stem cells, two major changes in the manufacturing process are anticipated. The first assumes that the source cells come from a master cell bank, thus allowing the same origin of cells to be supplied throughout the life cycle of the product. The second assumes that the main target of quality control in cell processing will shift from cell replication processes to cellular differentiation processes. Pluripotent stem cells can theoretically be amplified indefinitely and their expansion process has become relatively easy to manage in recent years [[8], [9], [10], [11]]. However, controlling the conditions of differentiation processes is complicated, and it often takes a long time to obtain target cells [12,13]. These differences must be reflected in the process and quality control requirements for production of cell-based products. The quality of cell-based products is prone to variability due to cell-processing operation of the manufacturing process, which causes intrinsic disorder of cells, described above. To ensure the reproducibility of process controls for cell manufacturing, it is important to design accelerations for the motion control of cell-processing operations in addition to controlling the cultivation conditions [14]. Therefore, a long education and training period will be required to maintain the quality of cell operations when the manufacturing process is performed manually by human operators. To ensure the required quality level is stably maintained throughout the life cycle of production, it is necessary to secure sufficient operators with the required operation skills, which makes production activities extremely expensive. It is assumed that the tolerance for variations due to cell-processing operations is large because there are large variations in somatic cells and tissue as raw materials for conventional manufacturing [15]. However, manufacturing using stem cells with a master cell bank is expected to require operators with more sophisticated mastery of skills for cell-processing operations. To maintain a certain number of required skilled operators throughout the life cycle of production, it is necessary to constantly secure personnel, including reserves, with consideration of unexpected vacancies or retirement. Extensive research and development of robotic operation system for the mechanization of manual cell-processing operations has been underway [[16], [17], [18], [19]]. The robotic operation here is mechanization and intended for mechanized operations of skilled cell-processing that make it difficult to reproduce operational parameters in the medium exchange or the passaging, and it is also necessary to achieve aseptic operation. For manufacturing using a master cell bank as raw material, the mechanization of cell-processing operations is an advantage for both the reproducibility and stability of product quality [20]. Indeed, it is assumed that robotic operations can increase reproducibility of product quality while reducing the cost of manufacturing [21,22]. Evaluating the cost-based effectiveness of cell manufacturing leads to reduced cost-of-goods in the life cycle of the product. It is expected that during the scale-up system of cell manufacturing, the life cycle cost imposed by robotic operations can be lower than that of manual operations, which have additional costs of securing personnel and education and training. It is presumed that characteristics impacting quality during operation are quite different between upstream processes (cellular expansion or differentiation) and downstream processes (dispensing or freezing of cells); thus, these processes need to be discussed individually [[23], [24], [25]]. In this study, we attempted to develop an estimation method for the resource expenditure required for manual or robotic operation in a cell manufacturing system using an isolator system, which assumes the upstream process for a manufacturing model of cell-based products. Resources required to achieve process control by manual or robotic operation were analyzed to lead the availability of robotic operation system.

Methods

Layout pattern using isolator system for performing processes

It is premised that all the cell manufacturing processes modeled in this study must have proper operational parameters for manual or robotic operation system that can be controlled within the design space to meet specified quality requirements for pharmaceutical production [26]. As shown in Fig. 1, a group of procedures for cell culture vessel-handling operation is adopted, and every process proceeds inside the sealed-chamber equipment such as a biosafety cabinet or an isolator system, referred to as the cell processing zone (CPZ), with a cleanness level of ISO class 5 (grade A) [16]. In this study, an isolator system is adopted. The surrounding area which is connected to the CPZ has a strong influence on the aseptic environment, so cleanliness level of ISO class 8 (grade C or D) is required for an isolator system to achieve aseptic processing, depending on the physical structure of CPZ. Operators need to gown when entering the surrounding area, which involves a series of procedures for washing and disinfecting hands, changing out of street clothes, and donning aseptic gowns. The required gowning level differs depending on the type or specifications of CPZ equipment, but it is assumed to be the same regardless of the equipment or operational specifications in this study.
Fig. 1

Diagram of manufacturing process and time schedule for repetition in a sealed-chamber cell manufacturing system. The operational cycle time for a cell processing cycle consists of 1st step for entering into the surrounding area, tent, 2nd step for material loading, tload, 3rd step for cell-processing operation, tcell, 4 step for cleaning, tclean, and 5th step for leaving from the surrounding area, tleav.

Diagram of manufacturing process and time schedule for repetition in a sealed-chamber cell manufacturing system. The operational cycle time for a cell processing cycle consists of 1st step for entering into the surrounding area, tent, 2nd step for material loading, tload, 3rd step for cell-processing operation, tcell, 4 step for cleaning, tclean, and 5th step for leaving from the surrounding area, tleav.

Requirement time of operational cycle for a process

As shown in Fig. 1, the operational cycle for cell-processing process has 5 steps with each required time, which consists of 1st step for entering into the surrounding area, tent [h] where is the gowning time of operators, 2nd step for materials loading, tload [h] where is the decontamination and setup time of materials, 3rd step for cell-processing operation, tcell [h] where is the actual cell-processing time in the process, 4 step for cleaning, tclean [h] where is the cleaning time for the processing area containing CPZ affecting next cycle, 5th step for leaving from the surrounding area, tleav [h] where de-gowning and removal time of operators. In practice, this cycle is repeated when processes for vessel-handling operation are underway in the CPZ, regardless of process characteristics.

Resource factors required to achieve aseptic-processing operation skills

The manufacturing of a product can be represented by the accumulation of resource expenditure with time for series of repeated processes. Such processes require aseptic-processing operation skills, including gowning technique, materials loading and cleaning, and additional cell-processing operation skills. The requirements for approving the operator or robot arms to perform processes were defined as shown in Table 1. The robot arms are machinery included in the robotic operation system.
Table 1

Essential factors for the formulation of resources in cell-processing operation.

resourceessential resource expenditure to achieve manufacturing process in production
during start-up to gain skills (initial costs)during production period (running costs)during the breaking period (upkeep costs)
operator with aseptic-processing operation skills (operator A)1) education and training time and cost required for aseptic-processing operation skills1) working time for processes in the manufacturing2) consumables for maintaining the environment (gowning and other supplies material)1) all other working time required for employees2) affairs required to secure reserve personnel with aseptic-processing operation skills
operator with cell-processing operation skills (operator B)1) education and training time and cost required for aseptic-processing operation skills2) education and training time and cost required for cell-processing operation skills with process monitoring skills1) working time for processes in the manufacturing2) consumables for maintaining the environment (gowning and other supplies material)1) all the other working time required for employees2) affairs required to secure reserve personnel with cell-processing operation skills
robot arms for cell-processing operation system (robot arms)1) design and assembly of equipment for cell manufacturing with aseptic-processing operation2) programme of cell-processing operations and monitoring operations1) utilities consumed (power and other supplies material)2) cleaning and disinfection cost required for reuse1) appropriate calibration and check at defined intervals with computer system validation2) replacement of major parts at defined intervals
Essential factors for the formulation of resources in cell-processing operation. To secure the resource of operator or robot arms with necessary operation skills, it is assumed that expenditures are incurred during start-up for design and actualization (initial), during production (running) period, and during the breaking period for maintenance. The resource expenditure for start-up is once as an initial investment, whereas expenditures during production period and the breaking period are required annual continuously. During the breaking period, the resource expenditure to upkeep proper cell processing operation skills (upkeep cost) requires. These expenditures during start-up do not only be required when production starts since demand of human resources occurs multiple times during the life cycle of production as an example in this setting. In this study, the resource expenditure for additional demands of human resource through the life cycle of the product is defined as the initial cost. Cell-processing operation work involves two tasks: controlled cell-processing operation and process monitoring to detect deviation, and two tasks cannot be done by one operator with cell-processing operation skills (operator B) in the same time. Therefore, manual operation is set to require two of the operator B. For robotic operation, robot arms with the operation system can combine the tasks of controlled cell operation and process monitoring, but requires only one operator with aseptic-processing operation skills (operator A) for materials loading and cleaning work, in this setting. The required resources for each process to maintain the required quality of manual or robotic operations are summarized in Fig. 2.
Fig. 2

Schematic image of required resources for manual operation and robotic operation in the cell-processing operation system.

Schematic image of required resources for manual operation and robotic operation in the cell-processing operation system.

Personnel life cycle by considering the periods of education and training

It is difficult to utilize all the time of employees for processes due to spend a certain amount of time outside of production activities. As shown in Fig. 3, when an operator is employed for the personnel lifecycle of average employment period, temp [h·(operator)−1], the period of education and training, ttra.asep [h·(operator)−1] and/or ttra.cell [h·(operator)−1] to secure the necessary operation skills for work cannot involve production activities. Therefore, the remaining period, which is obtained by subtracting the education and training period from the personnel life cycle, is period as performer of cell processing time for production. In addition, the practical manufacturing has to separate the periods of processing and non-processing. This consider that the available time for production, αrate·temp [h·(operator)−1], which is the net time for the operation cycle, can be calculated from the working time ratio available for production, αrate [-].
Fig. 3

Work timetable of one operator in the total employee time.

Work timetable of one operator in the total employee time. Furthermore, the period of education and training consumes human resources, as well as facility and equipment resources involving raw materials, to carry out training objectives. Since the temp may be shorter than the expected production period, tlife [year/production] where is the years of production corresponding to the product life cycle, it is necessary to always add maintenance expenditures (initial cost to demand human resources) that consider the replenishment or risk for unexpected retirements.

Machinery life cycle by considering the design and fabrication of manufacturing system

In this study, it is assumed that a machinery in the robotic operation system has a pair of robot arms and their operating system. At the start of production, the design and fabrication are required for the robot arms containing operating system of operational procedures, which is the first robotic operation system. With the increase in the number of annual batches, required unit number of the robot arms, nnec.robo [unit], are additionally fabricated by the initial design. The value of nnec.robo depends on the maximum available batch number per a robotic operation system, nrobo [batch·(unit)−1]. The robot arms are assumed to use consistently throughout the production period, although additional annual upkeep operation, including operating system validation, is required.

Estimation method of resource expenditure for cell operation

Because the contents and timing requirements of resource expenditure differ between operators and robot arms, the estimation of costs for cell manufacturing is integrated throughout the life cycle of production. On the basis of these assumptions, we carried out our estimations of resource expenditure for cell-processing operations, which is the basis for calculating the cost of goods in future by manual or robotic operation system. In this study, it is assumed that all procedures for the operation or management of facilities and equipment are common between manual and robotic operations. A series of upstream processes need to be carried out at prescribed intervals, and hence cannot be carried out continuously in the CPZ. Therefore, in this study, it is assumed that one CPZ is shared for processes of multiple batches proceeding in parallel to obtain an appropriate utilization rate of the CPZ. The education and training times for operators to gain aseptic-processing operation skills or cell-processing operation skills are stipulated as ttra,asep and ttra,cell, respectively. The model input for the cost estimation of manual operations is defined as ttra,cell, since t tra,asep to gain aseptic-processing operation skills will be a common value regardless of the product. The costs for education and training to acquire or upkeep operation skills are classified as initial costs or upkeep costs, but it is considered running costs since they are incurred on the basis of each operator. When the αrate·temp can be calculated, it is considered that the actual hourly rate of operator A or B after acquiring operation skills, cwor,A [JPY·h−1] or cwor,B [JPY·h−1], can be estimated using the following equation:where cemp [JPY·h−1] is the hourly personnel rate of the operator, ctra [JPY·h−1] is the hourly education and training rate, and cmai,A [JPY·(operator)−1] or cmai,B [JPY·(operator)−1] is the upkeep cost for operator A or B. cmai,A is only the upkeep cost for aseptic-processing operation skills while cmai,B also contains the resource expenditure for cell-processing operation skills, both are including re-education and training. According to the time schedule of the process shown in Fig. 1, the time required for each process, tproc [h], can be expressed by the following equation: Next, the expenditure for manual operation systems of a product, Cmanu [JPY·(product)−1], is estimated using the following equation:where nproc [(process)·(batch)−1] is the number of processes per batch in production and nlot [(product)·(batch)−1] is the number of products included in a batch for lot production. It is defined that the gowning costs for operators are charged for each process. The initial or upkeep cost can be calculated according to the respective ratio in the cwor, B and other expenditures is considered to be the running cost. In the model for cost estimation of robotic cell-processing operations, it is difficult to convert the initial design and fabrication of the robot arms into an hourly rate. Thus, the costs of initial design and fabrication, cdes [JPY] and fabrication and installation of robot arms with acquisition of operation skills, cfab [JPY·(unit)−1], are charged as the initial investment during start-up for production. Antithetically, it is assumed that robot arms can be used consistently throughout the production period, although cdes and cfab are required when production starts. The cdes is regarded as a one-time cost through the life cycle of production. The maximum number of batches, nrobo [batch·(unit)−1], that can be generated with one robotic operation system is appraised. When the annual number of batches required for production, nbat [batch·(year)−1], is used as the input value, the necessary unit number of robotic operation systems, nnec.robo [unit], is defined using the following equations:where αcapa [-] is the utilization rate of the CPZ including the robot arms, and tprod [h·(year)−1] reflects the annual business hours available for production. He expenditure for robotic operation system of a product, Crobo [JPY·(product)−1], is estimated using the following equation:where crsm [JPY·(unit·year)−1] is the upkeep cost of the robot arms including the operation verifying or computer system validation during the breaking period, and crse [JPY·(unit·year)−1] is the essential cost to maintain of the robotic operation system during production period. It is assumed that crsm and crse are defined as the upkeep cost to be charged annually, including the expenditure of operator A in the breaking period. The initial cost includes cdes and cfab, as well as the expenditures for demand of the human resource.

Production model conditions toward estimation

To estimate the resource expenditure for cell manufacturing, a life cycle of the production model was constructed for an iPSC-derived retinal pigment epithelial (RPE) cell manufactured using an isolator system [27]. As shown in Fig. 4, nproc was set to 90 in a production period of 91 days per a batch in the range of upstream processes, which involve iPSC expansion, differentiation, and maturation. The resource expenditure, Cmanu or Crobo, is estimated on the basis of the parameter values defined in Table 2, with nbat as the variable input value and tlife fixed to 10. Each value in Table 2 is empirically set on the basis of the common or the measured value from operational procedures in the model manufacturing, only to calculate the resource expenditure in this study. All values would need to be reviewed when another production model is developed for other organizations.
Fig. 4

Overview of a production model for iPSC-derived products.

Table 2

Nomenclature and values used for calculation.

symbolvalueunitexplanation
αcapa0.80capacity operating ratio of the CPZ
αrate0.80working time ratio available for the production
cdes1.0 × 108JPYinitial design cost of robotic operation system
cemp3.0 × 103JPY·(hour)-1basal hourly rate of operator
cfab1.0 × 108JPY·(unit)-1fabrication cost of robot arms and the operating system
cgow4.0 × 103JPY·(process)-1cost for materials of gowning
cmai,A5.0 × 105JPY·(operator)-1upkeep cost for operator A
cmai,B2.0 × 106JPY·(operator)-1upkeep cost for operator B
crse5.0 × 104JPY·(year)-1essential costs to maintain robotic operation system
crsm1.0 × 106JPY·(year)-1maintenance cost of robotic operation system
ctra6.0 × 103JPY·(hour)-1hourly cost preparing for education and training
nlot100product·(batch)-1number of product in a batch of manufacturing
nproc90process·(batch)-1number of process per batch in the manufacturing
tcell0.60hour·(process)-1working time for cell-processing operation
tclean0.50hour·(process)-1working time for cleaning
tent0.40hour·(process)-1working time for entering of operator
t emp1.0 × 104hour·(operator)-1average total employee time of operator
tleav0.30hour·(process)-1working time for leaving of operator
tlife10year/productionlife cycle period of the production
tload0.50hour·(process)-1working time for materials loading
tprod1.6 × 103hour·(year)-1manufacturing time in the facility
t tra,asep1.3 × 102hour·(process)-1education and training time for aseptic-processing
Overview of a production model for iPSC-derived products. Nomenclature and values used for calculation. Cmanu is estimated only from the cost of maintaining skilled operators and time associated with processes, whereas the number of batches performable by operator B, nmanu [batch·(operator)−1], is limited in reality. Therefore, the number of operator B required during the life cycle of production, nnec,ope [operator], is calculated using the following equations:

Results and discussion

When education and training time to gain required cell-processing operation skills of operator B were employed, the ttra,cell, was provided and the hourly rate of operator A or B, cwor,A or c wor, B, respectively, was estimated as shown in Fig. 5. As a matter of course, the cwor,B increased depending on ttra,cell, whereas cwor,A was constant. During cell manufacturing processes, constant quality can be ensured by acquiring both aseptic-processing operation skills and cell-processing operation skills, and ttra,cell for the latter would be unique for each product. Notably, the designed ttra,cell is expected to increase enormously if there are any complicated operations that are difficult to accrue for operators, which also depends on the cell manufacturability of the product model. Furthermore, the hourly rates in this production model are calculated by fixing the αrate at 0.7, but the decrease of αrate, which depends on decreasing the work engagement time for cell-processing of operators, will lead increase of the hourly rates. It is desirable that the αrate is higher in order to decrease the hourly rate, but it is assumed that the value of αrate is to be decrease when the number of personnel is secured in consideration of the retirement or other risks.
Fig. 5

Estimated hourly cost of a human operator considering the practical performance time for manufacturing processes depending on education and training time. (A) Operator with aseptic-processing operation skills (operator A), cwor,A. (B) Operator with cell-processing operation skills (operator B), cwor,B.

Estimated hourly cost of a human operator considering the practical performance time for manufacturing processes depending on education and training time. (A) Operator with aseptic-processing operation skills (operator A), cwor,A. (B) Operator with cell-processing operation skills (operator B), cwor,B. The resource expenditure adopted a manual cell-processing operation, Cmanu, in the production model that increased depending on ttra,cell, as shown in Fig. 6. Cmanu did not change with the value of nbat. Cmanu was 2.4 × 104 when ttra,cell was zero, whereas 2.9 × 104 when ttra,cell was 8.0 × 102 or 3.5 × 104 when ttra,cell was 1.6 × 103, which is the guidepost for half a year and one year of education and training period. Most of resource expenditures in the manual cell-processing operation was running cost, and the value was 2.2 × 104 when ttra,cell was zero, which was 91% in the Cmanu. The percentage of initial cost was as small as 2.5% when ttra,cell was zero, but it raised with the increase of ttra,cell. The initial cost became to be 2.2 × 104 when ttra,cell was 2.9 × 103, and the percentage of running costs in the Cmanu decreased to 49%. Since the work time of skilled operators is not occupied in certain processes and considered to be controlled by the value of αrate optionally, the operator costs in the running costs did not have marked increase.
Fig. 6

Estimated resource expenditure for cell manufacturing by the manual operation system, Cmanu. (A) Running costs in Cmanu. (B) Sum of running costs and upkeep costs in Cmanu. (C) Cmanu which is the sum of running costs, upkeep costs and initial costs.

Estimated resource expenditure for cell manufacturing by the manual operation system, Cmanu. (A) Running costs in Cmanu. (B) Sum of running costs and upkeep costs in Cmanu. (C) Cmanu which is the sum of running costs, upkeep costs and initial costs. In contrast, the resource expenditure adopted a robotic cell-processing operation, Crobo, that decreased with increasing nbat, because initial costs for design and fabrication of the robot arms are necessary, as shown in Fig. 7. The required number of robotic operation systems, nnec.robo [unit], fluctuated step by step relative to nbat and the decrease of Crobo value undulated because the robot arms needs to be occupied by certain processes. That is the trend of decrease contains the utilization rate change-related multiple lines of discontinuity when the nnec.robo increase with increasing nbat. Notably, this value settled around 3.0 × 104, when equilibrium with the increase in nbat was reached. The running cost was around 1.1 × 104 and constant regardless of nbat, the percentage was around 37% when Crobo reached in equilibrium. Although the initial cost was high when nbat was low, it decreased with increasing nbat, and the value settled around 1.7 × 104 when Crobo reached in equilibrium.
Fig. 7

Estimated resource expenditure for cell manufacturing by the robotic operation system, Crobo. (A) Running costs in Crobo. (B) Sum of running costs and upkeep costs in Crobo. (C) Crobo which is the sum of running costs, upkeep costs and initial costs.

Estimated resource expenditure for cell manufacturing by the robotic operation system, Crobo. (A) Running costs in Crobo. (B) Sum of running costs and upkeep costs in Crobo. (C) Crobo which is the sum of running costs, upkeep costs and initial costs. To compare manual and robotic operation system, Cmanu with ttra,cell of 8.0 × 102 or 1.6 × 103 and Crobo were evaluated. The results were exhibited with the number of operator B or robot arms required for the production model, as shown in Fig. 8. Cmanu was constant regardless of nbat. It was always 2.9 × 104 when ttra,cell was 8.0 × 102 and 3.5 × 104 when ttra,cell was 1.6 × 103. When ttra,cell was 8.0 × 102 or less, Crobo was higher than Cmanu. Compared with Cmanu when ttra,cell are 1.6 × 103, the value of Crobo was lower than Cmanu when nbat was 33 or more, but the reduction of Crobo was not remarkable even when nbat was increased further, because nbat has reached in equilibrium. Since these results of estimation are case study from parameters of a production model, the superiority of the certain operation method cannot be considered. Though it is suggested that comparison of different cell-processing operation methods is available by life cycle costing, which estimates the sum of running costs, upkeep costs and initial costs.
Fig. 8

Comparison of resource expenditure and required operators for manual and robotic cell-processing operation systems. (A) Cost for manual operation system, Cmanu when ttra.cell is 8.0 × 102. (B) Cost for manual operation, Cmanu when ttra.cell is 1.6 × 103. (C) Cost for robotic operation system, Crobo.

Comparison of resource expenditure and required operators for manual and robotic cell-processing operation systems. (A) Cost for manual operation system, Cmanu when ttra.cell is 8.0 × 102. (B) Cost for manual operation, Cmanu when ttra.cell is 1.6 × 103. (C) Cost for robotic operation system, Crobo. For manufacturing adopting a manual operation system, it was necessary to secure many workers with the required operation skills as nbat increased. This result implies that the increase of operator numbers is a serious potential risk in formulating a robust production plan. Indeed, manual operation systems need to consider that a certain percentage of operators will retire during the production period, so reserve employment and additional education or training will be required continuously to ensure the required number of operators are available throughout the life cycle of production. When the number of operators required increases depending on higher production demands, it is considered that the initial costs for the unit cost of each operator increase due to activities related to securing human resources, which occur irregularly. Furthermore, suppressing variations among operators is an important factor to assure the quality of products, especially when the process requires fine motion controls during cell-processing operations; accordingly, an increase in operator numbers becomes a great potential risk to carry out proper education and training. Thus, we assumed that these potential risks would increase Cmanu, yielding a higher than the expected cost-of-goods. The running cost in the robotic cell-processing operation was half of the running cost in the manual cell-processing operation. It is suggested that the number of operators, which is one in the robotic operation system compared to two in the manual operation system, led this result. On the other hand, Crobo was not sufficiently lower than Cmanu, even when nbat was greatly increased. Though we considered that the initial cost assumed is not much high, the percentage of initial cost didn't decrease enough with the increase of nbat. Unlike conventional processes for other medicinal products, the cell manufacturing processes in this method cannot be continuously performed by simply repeating the same cell-processing operation (tcell). Rather, the operation time of processes and accumulation of estimated resource expenditures in this study do not require the repetition of tcell by cell-processing operation but instead the repetition of tproc by combining times for activities such as materials loading, cleaning, and operators entering/leaving the CPZ. These results suggest that the reduction of Crobo is restricted when the process cycle induces a low utilization rate of the robot arms. Reportedly, robotic operation and closed systems can effectively reduce the cost-of-goods [22,28]. Closed systems involve a liquid-handling operation system adopting sealed vessels, such as a culture tank, and do not require extended occupation of the CPZ in which the robot arms are installed. These findings suggest that a reduction of tproc by shortening the time other than tcell in Equation (3), improves the utilization rate of robot arms, and reduces the cost-of-goods for manufacturing systems adopting robotic cell culture vessel-handling operations. There are two possible methods to reduce tproc relative to the improvement of the substantial utilization rate of CPZ and robot arms. One is to have a repetition of tcell in a cycle of the process, while the other is to shorten tproc while keeping tcell constant as mentioned above. However, it is suggested that the former is difficult or limited when considering cell manufacturability because the amounts of cells per batch increase [7]. Therefore, we have concluded that it is effective to shorten times for materials loading and/or cleaning to immediately improve the substantial utilization rate of CPZ and robot arms in manufacturing systems using cell culture vessel-handling operations. As a technical example, rapid loading methods employing a new decontamination technology permit operations in which the CPZ is continuously aseptic or maintained aseptic by cleaning without decontamination is assumed [29,30]. Furthermore, omitting the intervention of human operators with such methods is also profitable due to reduce the resource expenditure.

Conclusion

We developed an estimation method for the resource expenditure of cell-processing operations applied in cell manufacturing systems that involve vessel-handling procedures performed in a biosafety cabinet or an isolator system. The estimation method reported in this study adopted a life-cycle costing technique focused on cell-processing operations of the upstream process. Because procedures in the upstream process involve work such as entering the CPZ, loading materials, cell-processing operation, cleaning, and leaving the CPZ, reducing the time required for loading materials or cleaning can effectively improve the resource expenditure for cell-processing operations, thus reducing the cost of goods or products. In addition, a large number of operators is required for manually operated cell manufacturing systems when the number of batches in production is increased. The requirement to secure operators with appropriate operation skills is a great potential risk to the reproducibility of manufacturing processes. Therefore, it is suggested that cell manufacturing systems adopt robotic cell-processing operations for their advantages in stabilizing the production of cell-based products. Indeed, increasing the substantial utilization rate of robot arms can effectively reduce the resource expenditure of cell-processing operations. To increase the substantial utilization rate of robot arms, technologies that reduce the times required for materials loading or cleaning during each process are expected in the future.

Declaration of competing interest

None.
  26 in total

1.  Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering.

Authors:  Yuji Haraguchi; Katsuhisa Matsuura; Tatsuya Shimizu; Masayuki Yamato; Teruo Okano
Journal:  J Tissue Eng Regen Med       Date:  2013-06-03       Impact factor: 3.963

Review 2.  Stem Cell Therapies in Clinical Trials: Progress and Challenges.

Authors:  Alan Trounson; Courtney McDonald
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

3.  Apoptosis-based method for determining lot sizes in the filling of human-induced pluripotent stem cells.

Authors:  Hirokazu Sugiyama; Masaki Shiokaramatsu; Masashi Kagihiro; Kazuhiro Fukumori; Ikki Horiguchi; Masahiro Kino-Oka
Journal:  J Tissue Eng Regen Med       Date:  2020-09-17       Impact factor: 3.963

Review 4.  A roadmap for cost-of-goods planning to guide economic production of cell therapy products.

Authors:  Yonatan Y Lipsitz; William D Milligan; Ian Fitzpatrick; Evelien Stalmeijer; Suzanne S Farid; Kah Yong Tan; David Smith; Robert Perry; Jessica Carmen; Allen Chen; Charles Mooney; John Fink
Journal:  Cytotherapy       Date:  2017-09-19       Impact factor: 5.414

5.  Human cell culture process capability: a comparison of manual and automated production.

Authors:  Yang Liu; Paul Hourd; Amit Chandra; David J Williams
Journal:  J Tissue Eng Regen Med       Date:  2010-01       Impact factor: 3.963

6.  Validation of Contamination Control in Rapid Transfer Port Chambers for Pharmaceutical Manufacturing Processes.

Authors:  Shih-Cheng Hu; Angus Shiue; Han-Yang Liu; Rong-Ben Chiu
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

7.  iPS cell-based therapy for Parkinson's disease: A Kyoto trial.

Authors:  Jun Takahashi
Journal:  Regen Ther       Date:  2020-09-15       Impact factor: 3.419

8.  Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan.

Authors:  Kazuo Yano; Natsumi Watanabe; Kenichiro Tsuyuki; Taisuke Ikawa; Hiroshi Kasanuki; Masayuki Yamato
Journal:  Regen Ther       Date:  2014-11-11       Impact factor: 3.419

Review 9.  Automation in cell and gene therapy manufacturing: from past to future.

Authors:  P Moutsatsou; J Ochs; R H Schmitt; C J Hewitt; M P Hanga
Journal:  Biotechnol Lett       Date:  2019-09-20       Impact factor: 2.461

10.  Understanding the formation and behaviors of droplets toward consideration of changeover during cell manufacturing.

Authors:  Yuuki Ogawa; Manabu Mizutani; Ryuta Okamoto; Hideki Kitajima; Sachiko Ezoe; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2019-04-25       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.